Galapagos NV: Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn's and Colitis Organization (ECCO) annual congress
Nine presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityFour new analyses from Phase 3 SELECTION and SELECTION long term extension studies of Jyseleca
Source: finanznachrichten.de